RWE

Life Sciences Operations Outsourcing Is Expected to Grow 9-11% Through 2022 --Everest Group

Thursday, October 21, 2021 - 1:00pm

The rising demand for technological support is one of many trends compelling firms in the life sciences industry to rethink their strategy and operations.

Key Points: 
  • The rising demand for technological support is one of many trends compelling firms in the life sciences industry to rethink their strategy and operations.
  • The rise in spending will be partly utilized to purchase medication and MedTech devices, thereby boosting the life sciences market in the region.
  • Additionally, life sciences firms are increasingly outsourcing their R&D activities in a bid to reduce cost.
  • These trends have generated rapid traction in the life sciences outsourcing market as service providers accelerate their efforts to assist enterprises in augmenting their operations by delivering services and solutions across the life sciences operations value chain.

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Thursday, October 21, 2021 - 1:00pm

NEW YORK, Oct. 21, 2021 /PRNewswire/ --Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation.

Key Points: 
  • NEW YORK, Oct. 21, 2021 /PRNewswire/ --Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation.
  • FDA and Aetion will use Aetion Evidence Platform (AEP), validated software that enables efficient, transparent, and reliable RWE research, to develop a framework and system of studies for the rapid assessment of COVID-19 inpatient medical products.
  • Aetion and FDA will build on learnings from the research collaboration announced in May 2020, in which FDA and Aetion explored the utility of RWD to advance the understanding of and response to COVID-19.
  • The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value.

Seqirus Presents New Real-World Evidence Supporting Effectiveness of Differentiated Seasonal Influenza Vaccine Technologies at ISIRV-WHO Virtual Conference 2021

Tuesday, October 19, 2021 - 12:30pm

SUMMIT, N.J., Oct. 19, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE) supporting the effectiveness of its cell-based and adjuvanted seasonal influenza vaccines.

Key Points: 
  • SUMMIT, N.J., Oct. 19, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE) supporting the effectiveness of its cell-based and adjuvanted seasonal influenza vaccines.
  • "These retrospective studies, which include over 10 million vaccinated U.S. individuals, build on existing RWE in evaluating the effectiveness of influenza vaccines in real-world settings.
  • "These data support that our vaccines can help reduce IRMEs and minimize the burden of influenza, among children and older populations."
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.

UNITE Dubai - Middle East Private Wealth Gathers on Eve of Expo2020 to Discuss Investment, Trade and Philanthropy

Thursday, October 14, 2021 - 1:38pm

The World Humanitarian Forum, Part of the United Nations discussed topics such as 'Building Forward Better' and on their plans here in the UAE.

Key Points: 
  • The World Humanitarian Forum, Part of the United Nations discussed topics such as 'Building Forward Better' and on their plans here in the UAE.
  • UNITE Dubai and The Private Investment Group are proud to support such initiatives and do all that we can in promoting the UAE and the wider region.
  • The Middle East region's premier resource for informed news, features, and commentary covering sectors as construction, banking, technology and leisure in both English and Arabic.
  • Welthee, is a Decentralized Investment Fund that offers institutions and money managers a disruptive technology for unprecedented risk mitigation methods, diversification through a user-friendly platform.

Trinity Life Sciences Forms Partnership With Forian

Tuesday, October 12, 2021 - 3:29pm

Trinity Life Sciences, a leader in global life sciences solutions, announces a new partnership that enables Trinity EvidenceFirst to unlock streamlined, integrated insights using Forians real-world data (RWD) products.

Key Points: 
  • Trinity Life Sciences, a leader in global life sciences solutions, announces a new partnership that enables Trinity EvidenceFirst to unlock streamlined, integrated insights using Forians real-world data (RWD) products.
  • Trinitys new partnership with Forian will provide life sciences companies with the exact expertise and data they need to answer core and evolving business questions.
  • RWE experts from Trinity Life Sciences and Forian are offering a webinar on Brand Health Assessment, a key business need and an area where life sciences companies are driving evidence-based decisions.
  • Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences.

Radicle Science Announces XPRIZE Foundation and Singularity University Founder Peter H. Diamandis MD as Chair of Advisory Board

Tuesday, October 12, 2021 - 12:00pm

Notably, Peter H. Diamandis , MD joined as Chair of the Radicle Science Advisory Board in October 2021.

Key Points: 
  • Notably, Peter H. Diamandis , MD joined as Chair of the Radicle Science Advisory Board in October 2021.
  • He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the worlds leaders on exponentially growing technologies.
  • The co-founders of Radicle Science, Pelin and Jeff, along with the team whos joined their movement, are brilliant, passionate and inspiring.
  • To learn more about the Radicle Science-OBX alliance and our ongoing Radicle Science studies, visit our Radicle Resources page.

AOTI Participating in Multiple Leading Global Wound Care Conferences

Tuesday, October 12, 2021 - 1:46pm

OCEANSIDE, Calif., Oct. 12, 2021 /PRNewswire/-- Advanced Oxygen Therapy Inc. (AOTI) announced that it is proud to be supporting multiple leading global continuing medical education (CME) eligible wound care conferences across the remainder of 2021.

Key Points: 
  • OCEANSIDE, Calif., Oct. 12, 2021 /PRNewswire/-- Advanced Oxygen Therapy Inc. (AOTI) announced that it is proud to be supporting multiple leading global continuing medical education (CME) eligible wound care conferences across the remainder of 2021.
  • This time, participants from USA and Canada can register free of charge, due to an unrestricted grant provided by AOTI.
  • The Desert Foot Virtual Limb Salvage and Wound Care congress is held jointly with the Association for the Advancement of Wound Care (AAWC) from December 3 - 11, 2021.
  • Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is Proven to Deliver Sustained Wound Healing, So Life Can Get Back to Normal

Medidata Launches Medidata Link, the First Centralized Technology Solution to Connect and Analyze Patient-Level Clinical Trial Data and Real-World Data

Thursday, October 7, 2021 - 2:00pm

Medidata Link is the only centralized solution to connect patient-level clinical trial data and real-world data (RWD) powered by and fully integrated with the Medidata Unified Platform providing any clinical trial run on Medidata Rave EDC (electronic data capture) the option to conduct data linkage.

Key Points: 
  • Medidata Link is the only centralized solution to connect patient-level clinical trial data and real-world data (RWD) powered by and fully integrated with the Medidata Unified Platform providing any clinical trial run on Medidata Rave EDC (electronic data capture) the option to conduct data linkage.
  • This transformational capability bridges evidence gaps, and helps create the insights necessary to save time and bring more confidence in clinical decision making.
  • Medidata Link enables customers to generate a token to connect the patients clinical data in the Medidata Unified Platform to the industrys broadest RWD ecosystem in a secure, compliant, and scalable manner.
  • This creates a seamless integration with the rest of the clinical trial workflow and is agnostic of consent methods.

Syneos Health Acquires RxDataScience

Wednesday, October 6, 2021 - 1:16pm

MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience , a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company.

Key Points: 
  • MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience , a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company.
  • Together, Syneos Health and RxDataScience will offer biopharma customers technology-enabled, insights-powered solutions with the aim of accelerating performance across the product lifecycle from lab to life.
  • We are thrilled to welcome the RxDataScience team to the Syneos Health family.
  • RxDataScience will be part of the Syneos Health Dynamic Assembly network, an open ecosystem of best-of-breed data and technology collaborators designed to strategically address the nuances of unique customer engagements, providing an always on innovation environment.

Syapse Enters Real-World Data Collaboration with Merck to Inform and Improve Cancer Care

Wednesday, October 6, 2021 - 2:00pm

The collaboration will leverage real-world data (RWD) to drive high-quality insights that will impact patient care and advance oncology research.

Key Points: 
  • The collaboration will leverage real-world data (RWD) to drive high-quality insights that will impact patient care and advance oncology research.
  • Industry collaborations that bring to bear expertise in RWE, insights application, clinical care and life science innovation, such as the partnership between Merck and Syapse, will be pivotal in advancing cancer care overall.
  • Bringing together stakeholders from the entire oncology research, development and clinical spectrum, the Syapse Learning Health Network enables improved cancer care through collaboration.
  • Syapse is a company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care.